Understanding how lowering brain levels of the protein tau improves memory and other cognitive functions in mice genetically engineered to mimic Alzheimer's disease.
It deals with people suffering from Alzheimer's disease, slowly finding that familiar faces and items long cherished are slipping away from their memory.
The study is a randomized, double-blind, placebo-controlled, dose-ranging, safety and efficacy study in approximately 353 patients with mild to moderate Alzheimer's disease.